Retatrutides approach of adding glucagon activation to established GLP-1 and GIP effects opens metabolic possibilities that werent available even three years ago
Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type
At present, bariatric surgery (BS) is considered the benchmark treatment of morbid obesity, with well-established indications providing effective long-term outcomes [2, 3] that lead to sustained weight loss [4] and improvement in most weight-related comorbidities [5,6,7], with relatively low morbidity and mortality [8,9,10]
One user reported: "I have used GHK-cu injectable and topical and found no effect on E2 or DHT." The tradeoff is that GHK-Cu doesn't address the underlying hormonal cause of androgenetic alopecia
I feel better
Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes